Leah Hubbard, PhD

Program Director

Translational Research Program

Division of Cancer Treatment and Diagnosis,
National Cancer Institute
9609 Medical Center Drive, Room 3W212
MSC 9726
Bethesda, MD 20892
Phone (240) 276-5730
Fax (240) 276-7881
Email: leah.hubbard@nih.gov

Portfolios: Brain, and Head & Neck

Leah Hubbard, PhD is a Program Director in the Translational Research Program and Chief Diversity Officer in the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Hubbard has been a member of the Translational Research Program since 2013 and manages Specialized Programs of Research Excellence (SPOREs) in brain and head & neck cancer. Dr. Hubbard also participates in a number of NIH and NCI initiatives, including the U19 Glioblastoma Therapeutics Network RFA, the P20 Cancer Health Disparities SPORE RFA, the NIH UNITE Initiative, and the NCI Equity and Inclusion Program. Dr. Hubbard received her PhD in Immunology at the University of Michigan and continued her postdoctoral training at the National Institute of Allergy and Infectious Diseases at NIH. Dr. Hubbard's research training is in the area of innate immunity, with specific expertise in lung macrophage function and host defense; eicosanoid signaling; and syngeneic mouse modeling.